On May 31st, Tiama Inspection Worldwide announced the acquisition of VIMEC. Based in Eindhoven (Netherlands) and with more than 30 years of experience, VIMEC is one of the world’s leading companies in the field of non-molded glass control & inspection for the pharmaceutical industry segment.
VIMEC developed strong expertise in controlling vials, ampoules, syringes, and cartridges at different steps of their production thanks to its machine vision solutions.
Most recently, VIMEC has been providing dedicated services for the inspection of vials used for the COVID-19 vaccine.
Tiama’s objectives are to speed up VIMEC’s growth by developing synergies (R&D, purchasing, etc.) and increasing VIMEC’s Sales and Services presence to a worldwide level.
Tiama also plans to bring technologies it has already developed for food & beverage glass defect recognition (artificial intelligence, deep learning, etc.) to this pharmaceutical segment.
Share this article: